| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |